Here's a Spot | GenomeWeb

Here's a Spot

Stat News reports that Alphabet's Verily, Google's biotech company, has awarded a research contract to a luxury health clinic owned in part by Verily CEO Andrew Conrad. This contract, it adds, has raised eyebrows inside Verily as well as among corporate governance experts, Stat News adds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

On Their Way Out

For Truth

'Going Big'

New Verily Faces

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.